Integrated Model to Describe Morphine Pharmacokinetics in Humans

Area of Science:

• Pharmacology
• Pharmacokinetics
• Drug Metabolism

Background:

• Morphine pharmacokinetics (PK) are widely studied but lack quantitative synthesis across publications.
• Understanding morphine's absorption, distribution, metabolism, and excretion (ADME) is crucial for effective pain management.

Purpose of the Study:

• To quantitatively summarize and integrate existing knowledge on human morphine pharmacokinetics (PK).
• To develop a unified parent-metabolite PK model for morphine and its major glucuronide metabolites.

Main Methods:

• Digitized plasma concentration-time and urine recovery data from existing literature.
• Developed a parent-metabolite compartmental PK model to describe morphine and its metabolites (M3G, M6G).
• Integrated model results with mass balance studies to assess absorption and disposition.

Main Results:

• The developed PK model successfully described morphine and its metabolites' plasma concentrations and urinary recovery after IV and oral administration.
• The model differentiated the first-pass metabolism of morphine following oral intake.
• A comprehensive understanding of morphine absorption and disposition was achieved.

Conclusions:

• The parent-metabolite PK model provides a robust framework for understanding human morphine pharmacokinetics.
• This model can be extended to evaluate morphine PK in specific populations, including pediatrics and patients with renal impairment.
• This quantitative synthesis aids in optimizing morphine dosing and therapeutic strategies.